Skip to main content
Evidence-Ranked Guide

Best Peptides for Sexual Health & Libido

PT-141, gonadorelin, HCG and kisspeptin, ranked with the regulatory and safety caveats they demand.

Sexual-health peptides split into desire-focused (PT-141), reproductive-axis (gonadorelin, HCG, kisspeptin) and bonding-hormone (oxytocin) categories. We ranked by regulatory status and clinical evidence: PT-141 is FDA-approved for hypoactive sexual desire, HCG and gonadorelin have approved uses in fertility and hypogonadism, and kisspeptin is still in clinical trials. These compounds act on hormone systems — they require more caution, and usually medical supervision, than any other category in this guide.

The Ranked List

#1

Bremelanotide, FDA-approved (Vyleesi) for hypoactive sexual desire disorder; clinical-tagged improvements in desire and distress scores; nausea and flushing are common.

Reported dose: 1.75 mg as needed (SC)

Half-life: Variable

Route: SC

Read the full PT-141 (Bremelanotide) guide →
#2
GonadorelinFDA Approved

Synthetic GnRH with FDA approval that stimulates LH and FSH via the reproductive axis; medical supervision required.

Reported dose: 100 mcg 2–3× weekly

Half-life: 2-10 minutes

Route: SC/IV

Read the full Gonadorelin guide →
#3
HCG (Human Chorionic Gonadotropin)FDA Approved WADA banned

FDA-approved for fertility and hypogonadism; stimulates endogenous testosterone production; WADA-banned for athletes.

Reported dose: 250–500 IU 2–3× weekly

Half-life: 24-36 hours

Route: SC/IM

Read the full HCG (Human Chorionic Gonadotropin) guide →
#4
KisspeptinResearch

Reproductive modulator that triggers GnRH release; catalogued as research with ongoing clinical trials for fertility and libido support.

Reported dose: 100–200 mcg

Half-life: 4 minutes

Route: IV/SC

Read the full Kisspeptin guide →
#5
OxytocinFDA Approved

FDA-approved for labor induction and postpartum hemorrhage only (Pitocin); arousal and bonding claims are anecdotal-tier — clinician-directed use given hyperstimulation and water-intoxication risks.

Reported dose: 0.5–40 mIU/min IV infusion (clinician-directed)

Half-life: 3-5 minutes

Route: IV/Intranasal

Read the full Oxytocin guide →

Safety Note

Most compounds on this page are prescription drugs or research chemicals — not supplements. None of this content is medical advice: review each compound's full guide and safety note, respect WADA status if you compete, and consult a qualified clinician before making any health decision.

Frequently Asked Questions

What about Melanotan II?

We deliberately excluded it. Its catalogue safety note states it is not approved in any jurisdiction, has no safe protocol, and is associated with priapism and melanocytic changes. No ranking of best peptides should include it.

Is PT-141 the same as Melanotan II?

No — PT-141 (bremelanotide, Vyleesi) is a distinct melanocortin agonist FDA-approved for hypoactive sexual desire disorder. Melanotan-II shares the melanocortin family but has no approval anywhere.

Can I use these without medical supervision?

These act on reproductive and hormone systems. HCG and gonadorelin require medical supervision; oxytocin is approved only for labor induction and postpartum hemorrhage (Pitocin) with uterine-hyperstimulation and water-intoxication risks; PT-141 needs a prescription context.

Do desire peptides work for everyone?

No — PT-141 clinical data is specific to premenopausal women with hypoactive sexual desire, and kisspeptin evidence is still emerging from trials. Individual response and hormonal context vary widely.

Where Researchers Source Compounds

If you are exploring these compounds in a legitimate research setting, our partner store Peptide Hackers carries catalog-grade research peptides with third-party testing. We only link to suppliers we trust.

Visit Peptide Hackers →

Other Goals

Research purposes only. This ranking reflects the depth of published and catalogued evidence, not a recommendation to use any compound. Most peptides here are not approved for human use; always consult qualified medical professionals before making health decisions.